本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kymera Therapeutics, Inc.

74.42
-2.5400-3.30%
盤後74.430.0100+0.01%17:13 EDT
成交量:59.65萬
成交額:4,440.95萬
市值:60.76億
市盈率:-20.17
高:76.01
開:75.67
低:73.31
收:76.96
52周最高:103.00
52周最低:19.45
股本:8,164.24萬
流通股本:5,462.66萬
量比:0.90
換手率:1.09%
股息:- -
股息率:- -
每股收益(TTM):-3.6900
每股收益(LYR):-3.6900
淨資產收益率:-25.78%
總資產收益率:-15.87%
市淨率:3.85
市盈率(LYR):-20.17

資料載入中...

2026/03/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

重要事件披露

Form 8-K - Current report
2025/12/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities